Literature DB >> 6385376

The value of serial serum trough cyclosporine levels in human renal transplantation.

B D Kahan, C A Wideman, M Reid, S Gibbons, M Jarowenko, S Flechner, C T Van Buren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6385376

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  13 in total

Review 1.  Pharmacodynamic monitoring of cyclosporin.

Authors:  W M Awni
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 3.  Cyclosporine and rheumatoid arthritis.

Authors:  O Førre; K Waalen; H E Rugstad; K J Berg; D Solbu; E Kåss
Journal:  Springer Semin Immunopathol       Date:  1988

4.  Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects.

Authors:  J Grevel; E Nüesch; E Abisch; K Kutz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  The influence of haematocrit on blood cyclosporin measurements in vivo.

Authors:  A Johnston; J T Marsden; D W Holt
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

Review 6.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

7.  A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.

Authors:  A Lindholm; R Dahlqvist; G G Groth; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

8.  Cyclosporine trough concentration monitoring in liver transplant patients.

Authors:  G J Burckart; R J Ptachcinski; R Venkataramanan; S Iwatsuki; C Esquivel; D H Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1986-12       Impact factor: 1.066

9.  Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation.

Authors:  Usama Shalaby
Journal:  Jpn J Ophthalmol       Date:  2016-12-10       Impact factor: 2.447

Review 10.  Therapeutic monitoring of cyclosporin--an update.

Authors:  A Lindholm
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.